RxDoctor Payments Data

Sushama Scalera

Emergency Medicine · Salem, MANPI 1447484696

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,974,586 of the $3,996,134 with a category attached, or 99.5%. 5 manufacturers reported payments, led by Alnylam Pharmaceuticals Inc. at 42.4% of the total. 2025 is the largest year on record at $1,673,535, 8.3 times the $201,366 reported in 2021. Among emergency medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,996,134in general payments, 2019–2025

Across 118 payments — averaging $33,866 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$1.7M
  • Immunocore Limited$1.5M
  • Madrigal Pharmaceuticals$613K
  • Syndax Pharmaceuticals, Inc.$210K
  • Aquestive Therapeutics, Inc.$6K

What the payments were for

  • Consulting fees$3,974,58699%
  • Other$21,5481%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,996,134 in reported general payments places this provider in the 95th percentile of 1,429 emergency medicine providers in Massachusetts.

See all emergency medicine providers in Massachusetts

Other emergency medicine in Salem

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →